Table 1

Initiatives to mitigate the risk of purchasing poor-quality medicines

Risk mitigating strategies% of respondents
Procurement policies in place
 Recognising the pharmaceutical regulatory standards set by the WHO and/or Stringent Regulatory Authorities33
 Using positive lists of procurement agencies which have been assessed for compliance to WHO quality standards17
 Implementing some level of checks on medicine purchases done by implementing partners17
 Providing QA training to staff at donor and/or implementing partnersImplemented 42
Planned 17
 Monitoring use of donor funding channelled through UN agencies, GFATM25
Direct support to recipient countries
 Funding capacity building for pharmaceutical procurement/supply58
 Providing technical support from NMRA in the donor country, to NMRAs in LMICs42
 Providing QA training to Procurement Units17
 Funding national QC laboratory8
Indirect support to recipient countries
 Supporting the WHO Prequalification Programme17
 Supporting regional regulatory harmonisation initiative(s)25
 Supporting the WHO’s Global Surveillance and Monitoring System for SF products8
 Funding research and/or platforms providing technical support for implementing partners8
  • GFATM, Global Fund to fight AIDS, Tuberculosis and Malaria; LMICs, low-income and middle-income countries; NMRAs, national medicines regulatory authorities; QA, quality assurance; SF, substandard and falsified.